Search results for "palliative care."

showing 10 items of 329 documents

The "aRIANNA" Project: An Observational Study on a Model of Early Identification of Patients with Palliative Care Needs through the Integration betwe…

2018

Objective: The aim of this study was to illustrate the characteristics of patients with palliative care (PC) needs, early identified by general practitioners (GPS), and to analyze their care process in home PC services. Background: Early identification and service integration are key components to providing quality palliative care (PC) services ensuring the best possible service for patients and their families. However, in Italy, PC is often provided only in the last phase of life and for oncological patients, with a fragmented service. Methods: Multicenter prospective observational study, lasting in total 18 months, implemented in a sample of Italian Home Palliative Care Units (HPCUs), enr…

Malemedicine.medical_specialtyPalliative carepublic health approachDecision MakingintegrationPrimary care03 medical and health sciences0302 clinical medicineHome Health Nursingearly identificationmedicineHumansProspective Studies030212 general & internal medicineGeneral NursingNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and overpalliative carePrimary Health Carebusiness.industryGeneral MedicineIdentification (information)Early DiagnosisAnesthesiology and Pain MedicineSECS-S/03 - STATISTICA ECONOMICAItaly030220 oncology & carcinogenesisFamily medicineHospice and Palliative Care NursingFemaleObservational studybusiness
researchProduct

FACTORS AFFECTING THE DIAGNOSTIC DELAY IN AMYOTROPHIC LATERAL SCLEROSIS

2012

Abstract Background Although amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disorder, early diagnosis allows a prompt start with the specific drug riluzole and an accurate palliative care planning. ALS at onset may however mimic several disorders, some of them treatable ( e.g. , multifocal motor neuropathy) or epidemiologically more frequent ( e.g. , cervical myelopathy). Objective To study the delay from onset to diagnosis in a cohort of ALS patients and to the variables that may affect it. Methods We performed a retrospective analysis of the diagnostic delays in a cohort of 260 patients affected by ALS (M/F = 1.32) followed at our tertiary referral ALS Center between 20…

Malemedicine.medical_specialtyPediatricsDelayed DiagnosisPalliative careALS diagnostic delay cognitive errorsCohort StudiesHumansMedicineAge of OnsetDiagnostic ErrorsAmyotrophic lateral sclerosisAgedRetrospective Studiesbusiness.industryAmyotrophic Lateral SclerosisRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMultivariate AnalysisCohortPhysical therapyFemaleSurgerySettore MED/26 - NeurologiaNeurology (clinical)Age of onsetDifferential diagnosisbusinessCohort studyMultifocal motor neuropathy
researchProduct

The frequency of alcoholism in patients with advanced cancer admitted to an acute palliative care unit and a home care program

2015

Abstract Context Cancer patients with a history of alcoholism may be problematic. The frequency of alcoholism among patients with advanced cancer has never been reported in Italy or other European countries. Objectives The aim of this prospective study was to determine the frequency of alcoholism, assessed with a simple and validated instrument, among patients with advanced cancer who were referred to two different palliative care settings: an acute inpatient palliative care unit (PCU) of a comprehensive cancer center in a metropolitan area and a home care program (HCP) in a territorial district, localized in the mountains of Italy. Methods A consecutive sample of patients admitted to an in…

Malemedicine.medical_specialtyPediatricsPalliative careContext (language use)advanced cancer patientsNursingCancer Care Facilitiesadvanced cancer patients; Alcoholism; CAGE; palliative care; Anesthesiology and Pain Medicine; NursingSettore MED/42 - Igiene Generale E ApplicataInterviews as Topicadvanced cancer patientSex FactorsNeoplasmsSurveys and QuestionnairesmedicineHumansIn patientProspective StudiesKarnofsky Performance StatusPsychiatryProspective cohort studyGeneral NursingNursing (all)2901 Nursing (miscellaneous)Agedpalliative carePerformance statusbusiness.industryMedicine (all)Age FactorsCanceradvanced cancer patients; Alcoholism; CAGE; palliative care; Age Factors; Aged; Alcoholism; Female; Humans; Interviews as Topic; Italy; Karnofsky Performance Status; Male; Middle Aged; Neoplasms; Palliative Care; Prospective Studies; Sex Factors; Surveys and Questionnaires; Cancer Care Facilities; Home Care Services; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous); Medicine (all)Cancer Care FacilitiesMiddle Agedmedicine.diseaseHome Care ServicesAlcoholismAnesthesiology and Pain MedicineItalyCAGEFemaleNeurology (clinical)Care programbusiness
researchProduct

Association between alcoholism and symptom expression, patient symptom goals, and clinical response in advanced cancer patients

2019

Aim: The aim of this study was to determine the influence of alcoholism on symptom expression, personalized symptom goal (PSG) and patient goal response (PGR), and patient global impression (PGI) in advanced cancer patients. Methods: This was a secondary analysis of an international multicenter study. Advanced cancer patients who had a history of alcohol dependence positive, according to CAGE (cut down, annoy, guilt, eye-opener), were selected. Thirty patients (3.45%) were CAGE-positive. This sample was matched with 30 patients with similar characteristics who were CAGE-negative. Patients rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission (T0) and the…

Malemedicine.medical_specialtyWeaknessPalliative careNauseaPain medicine03 medical and health sciences0302 clinical medicineNeoplasmsStatistical significanceInternal medicinemental disordersHumansMedicine030212 general & internal medicineAgedGlobal impressionbusiness.industryMinimal clinically important differenceAlcohol dependencePatients’ goalAdvanced cancerAdvanced cancer patientAlcoholismOncology030220 oncology & carcinogenesisClinical responseSymptom burdenFemalelipids (amino acids peptides and proteins)Symptom Assessmentmedicine.symptombusinessGoals
researchProduct

Controlled sedation for refractory symptoms in dying patients.

2008

Terminally ill cancer patients near the end of life may experience intolerable suffering refractory to palliative treatment. Although sedation is considered to be an effective treatment when aggressive efforts fail to provide relief in terminally ill patients, it remains controversial. The aim of this study was to assess the need and effectiveness of sedation in dying patients with intractable symptoms, and the thoughts of relatives regarding sedation. A prospective cohort study was performed on a consecutive sample of dying patients admitted to an acute pain relief and palliative care unit within a cancer center. Indications for sedation, opioid and midazolam doses, level of delirium and s…

Malerefractory symptomPalliative carePalliative treatmentSedationPainRefractoryNeoplasmscontrolled sedationmedicineHumansProspective cohort studyGeneral NursingPain MeasurementTerminal Caredying patientsbusiness.industryPalliative CareMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineTreatment OutcomeOpioidAnesthesiaMidazolamDeliriumFemaleNeurology (clinical)medicine.symptombusinessmedicine.drug
researchProduct

Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: Clinical features and survival analysis

2012

article i nfo Background: Tracheostomy mechanical ventilation (TMV) is performed in amyotrophic lateral sclerosis (ALS) patients with a respiratory failure or when the non-invasive ventilation (NIV) is no longer effective. We evaluated the clinical characteristics and survival of a cohort of tracheostomized ALS patients, followed in a single ALS Clinical Center. Methods: Between 2001 and 2010, 87 out of 279 ALS patients were submitted to TMV. Onset was spinal in 62 and bulbar in 25. After tracheostomy, most patients were followed up through telephone interviews to caregivers. A complete survival analysis could be performed in fifty-two TMV patients. Results: 31.3% ALS patients underwent tra…

Mechanical ventilationmedicine.medical_specialtyPalliative carebusiness.industrymedicine.medical_treatmentals tracheostomy survivalmedicine.diseaseSurgeryNeurologyRespiratory failureInterquartile rangeAnesthesiamedicineSettore MED/26 - NeurologiaNeurology (clinical)Age of onsetAmyotrophic lateral sclerosisbusinessProspective cohort studySurvival analysisJournal of the Neurological Sciences
researchProduct

Combination chemotherapy with mitomycin C, vindesine and melphalan for refractory metastatic breast cancer.

1991

A combination of mitomycin C, vindesine and melphalan was administered to 33 patients with heavily pretreated refractory breast cancer. The overall response rate was 27% with a mean duration of more than 10.2 months. A stabilization with a mean duration of 5.1 months was seen in 56% of cases, while 20% of patients progressed. Gastrointestinal toxicity, mostly grade 1 or 2 nausea/vomiting was seen in 85% of cases, grade 1 or 2 leukopenia in 60% of patients, and grade 1 or 2 thrombocytopenia in 42%. Considering the good compliance of this regimen and the poor prognosis of patients with refractory advanced breast cancer, this combination can be useful as a palliative treatment of breast carcin…

MelphalanOncologyAdultCancer Researchmedicine.medical_specialtyVindesinemedicine.medical_treatmentMitomycinBreast NeoplasmsMitomycinsBreast cancerInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansNeoplasm MetastasisMelphalanAgedChemotherapybusiness.industryMitomycin CPalliative CareCancerCombination chemotherapyGeneral MedicineMiddle Agedmedicine.diseaseMetastatic breast cancerOncologyVindesineFemalebusinessmedicine.drugJournal of cancer research and clinical oncology
researchProduct

Symptom burden in mesothelioma patients admitted to home palliative care

2016

Context: Mesothelioma is a very aggressive cancer that is brought on by asbestos exposure. Because there is a long latency period between exposure to asbestos and symptoms of disease, most patients with mesothelioma present with advanced disease and survive an average of 8–12 months. Thus, best supportive care should be considered critical to optimally manage these patients. Aim: The aim of this study was to examine the epidemiological characteristics and symptom burden of mesothelioma patients when admitted to home palliative care. Methods: The charts of a consecutive sample of patients admitted to the home palliative care program with a diagnosis of mesothelioma in an endemic industrial…

MesotheliomaHome Care ServiceMalemedicine.medical_specialtyPalliative careDiseasemedicine.disease_causeAsbestos03 medical and health sciences0302 clinical medicineRetrospective StudieEpidemiologymedicineHumans030212 general & internal medicineMesotheliomaIntensive care medicineRetrospective StudiesAgedAged 80 and overbusiness.industryMedicine (all)Palliative CareSymptom burdenRetrospective cohort studyGeneral MedicineCancer PainMiddle Agedmedicine.diseaseHome Care ServicesAnalgesics OpioidDyspnea030220 oncology & carcinogenesisEmergency medicineFemalebusinessCancer painHuman
researchProduct

Orphan symptoms in advanced cancer patients followed at home

2013

Abstract Orphan symptoms are rarely assessed, particularly at home. The aim of this multicenter prospective study was to assess the prevalence of these symptoms and eventual factors possibly associated in advanced cancer patients at admission of a home care program. A prospective study was performed at three home care programs in Italy. Patients' data were collected, including age, sex, diagnosis, and Karnofsky status. Possible contributing factors were analyzed; preexisting neurological diseases, cerebral metastases, hyperthermia, diabetes, a state of dehydration clinically evident and/or oliguria, possible biochemical parameters when available, data regarding recent chemotherapy, opioids …

MyoclonusMalemedicine.medical_specialtyPalliative careHiccup; Home care; Myoclonus; Palliative care; Pruritus; Sweating; Tenesmus; Aged; Analgesics Opioid; Female; Fentanyl; Hiccup; Home Care Services; Hospitalization; Humans; Italy; Karnofsky Performance Status; Male; Myoclonus; Neoplasms; Prospective Studies; Pruritus; Sweating; Oncology; Medicine (all)Hiccup; Home care; Myoclonus; Palliative care; Pruritus; Sweating; TenesmusSweatingOpioidSettore MED/42 - Igiene Generale E ApplicataHome careFentanylHiccupPrurituOliguriaInternal medicineDiabetes mellitusNeoplasmsMedicineHumansVesical tenesmusProspective StudiesKarnofsky Performance StatusProspective cohort studyAgedAnalgesicsbusiness.industryPruritusMedicine (all)Tenesmusmedicine.diseaseHome Care ServicesAnalgesics OpioidFentanylHospitalizationDistressItalyOncologyAnesthesiaPalliative careFemalemedicine.symptombusinessMyoclonusMyoclonumedicine.drug
researchProduct

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids

2013

Objectives: The aim of this exploratory study was to assess the conversion ratios between tapentadol and other opioids in patients requiring an opioid switching. Methods: A prospective study was carried out in a convenience sample of consecutive patients admitted to an acute palliative care unit and a home care unit for a period of 1 year. Patients who were switched from/to tapentadol were selected. The initial ratio between tapentadol and other opioids, expressed as oral morphine equivalents was 1:3.3. The subsequent doses were flexible and were changed to fit the patients’ needs. Pain intensity and distress score were recorded until opioid doses were stable. In all, 37 patients were exami…

NarcoticsPalliative careReceptors Opioid muPainSettore MED/41 - AnestesiologiaOpioidPhenolsNeoplasmsReceptorsmedicineHumansIn patientProspective StudiesCancer painProspective cohort studyConversion ratioAnalgesicsMorphinebusiness.industryMedicine (all)Palliative CareCancerGeneral MedicineTapentadolmedicine.diseaseAnalgesics OpioidTapentadolOpioidmuDelayed-Action PreparationsAnesthesiaCancer pain; Conversion ratio; Opioid switching; Tapentadol; Analgesics Opioid; Delayed-Action Preparations; Humans; Morphine; Narcotics; Neoplasms; Pain; Palliative Care; Phenols; Prospective Studies; Receptors Opioid mu; Medicine (all)Opioid switchingExtended releasebusinessCancer painCancer pain Conversion ratio Opioid switching Tapentadol Analgesiamedicine.drugCurrent Medical Research and Opinion
researchProduct